Skip to main content

Tag: 2026

Q&A with Dr. Alexander Khoruts, Director of the Microbiota Therapeutics Program, UMN

Written by Julie B. O'Brien on . Posted in News, OpenDialog.

OpenDialog May 2026 – Issue Two

Patient outcomes may depend on science that’s moving faster than any of us can track. OpenBiome Foundation’s monthly newsletter cuts through the noise – delivering focused conversations in Q&A format with leading researchers and clinicians on the microbiome discoveries most relevant to your practice. No jargon, no fluff. Just the insights worth your time.

This second edition features an innovative leader in microbiome discoveries and for C. difficile and its treatments. He is Dr. Alexander Khoruts, Director of the Microbiota Therapeutics Program, UMN.

OpenBiome Foundation Announces New Board Leadership

Written by Julie B. O'Brien on . Posted in News.

Today, the OpenBiome Foundation announced the unanimous election of its Board Leadership for a three-year term, effective immediately. The officers, representing a cross section of innovators – from the clinical, patient, technology and financial fields – will guide the Foundation in its mission to expand patient access to microbiome therapies and drive scientific discoveries that will shape the future of health. 

Q&A with Dr. Cliff McDonald, CDC

Written by Media on . Posted in News, OpenDialog.

OpenDialog March 2026 – Issue One

Patient outcomes may depend on science that’s moving faster than any of us can track. OpenBiome Foundation’s monthly newsletter cuts through the noise – delivering focused conversations with leading researchers and clinicians on the microbiome discoveries most relevant to your practice. The first edition features Dr. L. Clifford McDonald, MD, Associate Director for Science in the Division of Healthcare Quality Promotion (DHQP) at the Centers for Disease Control and Prevention (CDC), one of the foremost experts in Clostridioides difficile (C. difficile) epidemiology.